RAND CAPITAL CORP (RAND) stock: key figures, P/E, revenue and dividend
Financials · United States · ISIN US7521852076
RAND CAPITAL CORP financials
| Fiscal year | 2025 |
|---|---|
| EBIT | -8.10 m USD |
| Net income | -8.04 m USD |
| Diluted EPS – continuing operations | -2.73 USD |
Full history since 1994, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About RAND CAPITAL CORP
Rand Capital Corporation is a business development company specializing in subordinated debt with warrants or preferred equity and venture capital investments. Within private equity, the firm specializing in capital growth and lower middle market investments. Within venture capital, it specializing in early to late-stage private businesses. It does not prefer to invest in real estate sector. It prefers to invest in software, professional services, manufacturing, consumer, healthcare, automotive and public d stocks. It prefers to invest in East or Midwest U.S. operations sectors. It typically invests between $0.75 million and $5 million with initial target size of $1.5 million. It seeks to invest in companies having more than $10 million in revenue or having excess of $1.5 million and up to $5 million in EBITDA. It prefers to be a minority stake and seeks to take a Board seat in its portfolio companies. It typically holds its investments for a period up to five years.
More stocks
- Holistic Asset Finance Group Co., Ltd. (HAFG)
- SCANDIUM INTERNATIONAL MINING CORP. (SCYYF)
- MARIMED INC. (MRMD)
- Laird Superfood, Inc. (LSF)
- ROCKWELL MEDICAL, INC. (RMTI)
- ENERGY FOCUS, INC/DE (EFOI)
- QS Energy, Inc. (QSEP)
- iANTHUS CAPITAL HOLDINGS, INC. (ITHUF)
- Planet 13 Holdings Inc. (PLNH)
- MILESTONE SCIENTIFIC INC. (MLSS)
- MIRA PHARMACEUTICALS, INC. (MIRA)
- Hyperscale Data, Inc. (GPUS)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.